Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Rosetta Stone Inc (RST): Osmium Trims Stake in Its Top Pick, Plus Fund’s Other Top Holdings

Page 1 of 2

John H. Lewis’ Osmium Partners revealed in a filing with the SEC last week that it has trimmed its stake in its largest holding, Rosetta Stone Inc (NYSE:RST) by about 7%, selling 148,500 shares in a number of transactions in 2015, the majority of which took place in early March. After the sales, Osmium holds 1.98 million shares, representing a 9.3% activist stake in the company.

Rosetta Stone Inc

Osmium Partners is a value-based long/short fund founded in 2002 by Lewis. The fund invests primarily in small-cap companies with market values of less than $1 billion, particularly in undervalued companies with strong but misunderstood business models. The fund maintains a small, concentrated equity portfolio, with 23 long positions as of the end of 2014, with the fund’s top five picks accounting for over 50% of the value of the portfolio. Moreover, 67% of the fund’s equity portfolio was invested in tech stocks.

Leading that portfolio was Rosetta Stone Inc (NYSE:RST), which accounted for 15.20% of Osmium’s portfolio at the end of 2014, remaining the fund’s top pick for the second straight quarter. Its 2.13 million shares at the time were valued at $20.78 million. While gross margins are high, sales of the company’s language learning software dissapointed investors for much of 2014, which led to a 20.65% loss on the year. Shares are also down a hefty 66.94% since its IPO.

Despite that, there is a lot to like about the company, which looks very undervalued in a number of key metrics. Most notable is the Enterprise-Value-to-Sales (EV/Sales) ratio of just 1.2x, well below the education industry average of 3.7x. Rosetta Stone Inc (NYSE:RST) reports its fourth quarter results on Wednesday, with David Nierenberg of Nierenberg Investment Management likely to be one of the most interested parties. Nierenberg owns around 1.51 million shares as of the end of 2014; the $14.78 million stake amasses 19.66% of its equity portfolio, which is the largest share among the funds that we track.

Nierenberg last summer welcomed the news that Osmium had changed its stake in Rosetta Stone from passive to activist, and hoped the fund would bring the same passion to guiding Rosetta Stone that it had shown in some of its other activist positions of late.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!